Amgen Inc (NASDAQ:AMGN) - Share price - Overview

Stock Report

Amgen Inc AMGN

Last Price
$171.94

Day Change
-2.72|-1.56%

As of 24/04/2018
16:14:32 EDT | USD
Minimum 15 Minutes Delay.

Last Close174.66
Day Range170.53 - 175.76
Mkt Cap116.70Bil
52-Wk Range152.16 - 201.23
Yield %2.73
ISINUS0311621009
Volume4,319,469
P/E63.92
P/S5.53
P/CF11.31

Share Price

Financials
201520162017
More ...
Income Statement
Revenue21,662.0022,991.0022,849.00
Operating Income8,470.009,794.009,973.00
Net Income6,939.007,722.001,979.00
Basic EPS9.1510.322.71
Avg. Diluted Shares Outstanding766754735
Balance Sheet
Current Assets38,518.0046,010.0049,476.00
Non Current Assets33,058.0031,616.0030,478.00
Total Assets71,576.0077,626.0079,954.00
Current Liabilities8,667.0011,204.009,020.00
Total Liabilities---
Total Equity28,083.0029,875.0025,241.00
Cash Flow
Operating Cash Flow9,077.0010,354.0011,177.00
Capital Expenditure-649.00-837.00-664.00
Free Cash Flow8,428.009,517.0010,513.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

20,800
Key Stats
More ...
Price/Earning TTM64.45
Price/Book4.62
Price/Sales TTM5.62
Rev Growth (3 year avg)4.43
EPS Growth (3 year avg)-
Operating Margin % TTM43.65
Net Margin % TTM8.66
ROE TTM7.18
Debt/Equity1.35
Dividends
PreviousLatest
More ...
Declared Date12/12/1707/03/18
Ex-Div14/02/1816/05/18
Paid08/03/1808/06/18
Amnt1.321.32
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.